Skip to main content
SpringerLink
Log in

Ipriflavone influences the osteoblastic phenotype in Vitro

  • Session XI: Treatment: Fluoride, Bisphosphonates, Anabolic Steroids And New Developments
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Willaman JJ. Some biological effects of flavonoids. J Am Pharm Assoc 1955;44:404–7.

    Google Scholar 

  2. Benvenuti S, Tanini A, Frediani U, et al. Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line. J Bone Miner Res 1991;6:987–96.

    Google Scholar 

  3. Bradbury RB, White DE. Estrogens and related substances in plants. Vitam Horm 1955;12:207–33.

    Google Scholar 

  4. Bickoff EM, Livingston AL, Hendrickson AP, Booth AN. Relative potencies of several estrogenlike compounds found in forages. Agric Food Chem 1962;10:410–12.

    Google Scholar 

  5. Shutt DA, Cox RI. Steroid and phytoestrogen binding to sheep uterine receptors in vitro. J Endocrinol 1972;52:299–310.

    Google Scholar 

  6. Cheng E, Yoder L, Story CD, Burroughs W. Estrogenic activity of some isoflavone derivatives. Science 1954;120:575–7.

    Google Scholar 

  7. Yamazaki I. Effects of ipriflavone on the response of uterus and thyroid to estrogen. Life Sci 1986;38:757–64.

    Google Scholar 

  8. Yamazaki I, Shino A, Shimizu Y, Tsukuda R, Shirikawa Y, Kinoshita M. Effect of ipriflavone on glucocorticoid-induced osteoporosis in rats. Life Sci 1986;38:951–8.

    Google Scholar 

  9. Yamazaki I, Shino A, Tsukuda R. Effect of ipriflavone on osteoporosis induced by ovariectomy in rats. J Bone Miner Metab 1986;3:205–10.

    Google Scholar 

  10. Shino A, Matsuo T, Tsuda M, et al. Effect of ipriflavone on bone and mineral metabolism in the streptozotocin diabetic rats. J Bone Miner Metab 1986;3:27–37.

    Google Scholar 

  11. Yoshida K, Tsukamoto T, Torii H, et al. Disposition of ipriflavone (TC-80) in rats and dogs. Radioisotopes 1985;34:618–23.

    Google Scholar 

  12. Tsuda M, Kitazaki T, Ito T, Fujita T. The effect of ipriflavone (TC-80) on bone resorption in tissue culture. J Bone Miner Res 1987;1:207–11.

    Google Scholar 

  13. Sziklai I, Ribari O. The effect of flavone treatment on human otosclerotic ossicle organ cultures. Arch Otorhinolaryngol 1985;242:67–70.

    Google Scholar 

  14. Ribari O, Sziklai I. Effect of flavonoid on PGE2-induced alterations in percentage collagen synthesis is ossicle organ cultures. Acta Otolaryngol 1987;103:657–60.

    Google Scholar 

  15. Caputo CB, Meadows D, Raisz LG. Failure of estrogens and androgens to inhibit bone resorption in tissue culture. Endocrinology 1976;98:1065–8.

    Google Scholar 

  16. Ousler MJ, Pyfferoen J, Osdoby P, Spelsberg T. Avian osteoclast gene responses to 17-beta-estradiol treatment. J Bone Miner Res 1991;6:S297.

    Google Scholar 

  17. Ernst M, Schmid CH, Froesch ER. Enhanced osteoblast proliferation and collagen gene expression by estradiol. Proc Natl Acad Sci USA 1988;85:2307–10.

    Google Scholar 

  18. Eriksen E, Colvard DS, Berg NJ, et al. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 1988;241:84–6.

    Google Scholar 

  19. Komm BS, Terpening CM, Benz DJ, et al. Estrogen binding, receptor mRNA and biological response in osteoblastlike osteosarcoma cells. Science 1988;241:240–3.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Physiopathology, University of Florence Medical School, Florence, Italy

    M. L. Brandi

Authors
  1. M. L. Brandi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brandi, M.L. Ipriflavone influences the osteoblastic phenotype in Vitro. Osteoporosis Int 3 (Suppl 1), 226–229 (1993). https://doi.org/10.1007/BF01621914

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01621914

Keywords

Search

Navigation